Testosterone metabolism of equine single CYPs of the 3A subfamily compared to the human CYP3A4.

This study delves into the comparison of testosterone metabolism in horses and humans, focusing on the functioning of isoenzymes present in the Cytochrome P450 (CYP) 3A subfamily. The understanding of these single CYPs can aid in predicting the effects of drugs and avoiding potential adverse effects or reduced drug efficacy.

Methodology

• Three equine isoenzymes of the 3A CYP subfamily were cloned, sequenced, and expressed in a baculovirus expression system for study.
• Testosterone, the standard compound for characterizing the human CYP3A4, was utilized to study and understand the expressed equine CYPs functionality.

Findings

• The metabolism results showed similarity in patterns between equine and human CYPs, but the amounts of metabolites differed according to the isoform in question.
• All equine CYPs generated 2-hydroxytestosterone (2-OH-TES), a metabolite that had not previously been described in horses before this study.
• The key metabolite of CYP3A4, 6β-hydroxytestosterone (6β-OH-TES), was found in minute quantities within equine CYPs 3A95 and 3A97.
• The application of Ketoconazole, an antifungal medication, resulted in total inhibition of 2-OH-TES in both the human CYP3A4 and the equine CYP3A94 and CYP3A97. A 70% inhibition was documented with CYP3A95.

Implications

• The hydroxylation of testosterone in equine CYPs showed significant differences when compared to that in CYP3A4.
• By expressing and studying individual equine CYPs, the research allows for a more in-depth understanding of drug and substance metabolism in equines.
• Such study potentially provides valuable knowledge towards preventing damaging drug-drug interactions, leading to safer and more effective drug use in horses.